Spero Therapeutics SPRO Balance Sheet (2016-2026)

NASDAQ SPRO
$1.15 -0.02 (-1.71%)
As of: Sep 10, 2026 · 12:30 PM EDT
Reported Financials

Spero Therapeutics Quarterly Balance Sheet

Periods 40 quarters
Latest Jun 2026

Spero Therapeutics reported total assets of $52.77M and total liabilities of $8.56M for the quarter ended Jun 2026, down 15.1% year over year. This balance sheet covers 40 quarters of results from Sep 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
112.86M112.58M72.11M45.40M50.45M109.11M96.25M77.69M93.83M76.33M82.27M63.53M76.29M52.89M48.89M31.19M48.62M40.27M56.13M50.77M
Short-term InvestmentsInvestments (Current)
10.56M33.82M49.85M
Cash & Current Investments
123.42M146.40M121.97M45.40M50.45M109.11M96.25M77.69M93.83M76.33M82.27M63.53M76.29M52.89M48.89M31.19M48.62M40.27M56.13M50.77M
Receivables - NetNet Receivables
49.15M49.20M50.76M50.59M49.39M23.61M24.45M0.87M25.36M
Receivables - OtherOther Receivables
2.24M0.04M1.62M1.56M0.91M0.13M1.86M2.09M2.99M-1.44M5.02M4.73M2.70M0.39M-2.42M2.46M1.59M-1.56M0.04M-0.02M
Receivables
0.13M47.71M54.22M55.49M53.28M49.78M21.19M26.91M2.46M23.80M0.04M-0.02M
Prepaid Assets
5.77M8.83M8.75M4.97M1.49M3.38M3.54M8.57M5.41M4.18M3.67M3.20M2.06M1.91M1.55M1.29M1.25M1.63M1.44M0.79M
Current Assets
131.77M157.87M132.70M51.95M52.89M113.57M101.66M88.35M102.22M131.21M140.15M122.22M131.63M107.28M74.71M59.40M52.32M67.29M57.61M51.58M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
1.21M1.03M0.89M0.62M0.49M0.37M0.26M0.15M0.04M0.00M0.00M
Other Non-Current Assets
5.21M5.64M5.93M5.47M5.74M5.74M5.74M5.74M0.43M0.43M0.43M0.43M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M
Non-Current Assets
12.92M13.20M13.13M11.67M11.59M11.23M10.88M10.54M4.88M51.18M27.55M27.66M3.53M3.27M3.00M2.72M1.85M1.63M1.41M1.18M
Assets
144.69M171.07M145.83M63.63M64.48M124.80M112.55M98.89M107.10M182.39M167.70M149.88M135.16M110.54M77.71M62.12M54.17M68.92M59.02M52.77M
Liabilities
Current Liabilities
Accounts Payables
3.16M1.10M4.78M1.71M2.58M0.62M0.58M1.31M1.10M1.38M3.07M2.70M6.09M7.31M1.76M0.78M1.40M0.69M0.22M0.15M
Notes Payables
0.99M0.12M0.14M
Payables
3.16M1.10M5.78M1.83M2.72M0.62M0.58M1.31M1.10M1.38M3.07M2.70M6.09M7.31M1.76M0.78M1.40M0.69M0.22M0.15M
Accumulated Expenses
11.36M14.35M9.06M8.51M8.09M8.97M8.86M5.60M6.56M6.56M5.38M10.01M15.33M17.72M8.19M6.73M7.81M5.58M3.14M6.11M
Other Accumulated Expenses
1.28M1.24M1.06M0.52M0.21M0.21M0.17M0.16M1.20M0.24M0.21M0.11M0.19M0.12M0.10M0.09M0.08M0.13M0.07M0.09M
Current Leases
1.04M1.36M1.37M1.53M1.68M1.69M1.70M1.70M1.71M1.72M1.73M1.73M1.74M1.75M1.79M1.84M1.90M1.96M1.97M2.00M
Current Taxes
2.21M0.39M0.39M0.39M0.10M0.17M0.17M0.16M0.16M0.38M0.16M0.16M
Current Deferred Revenue
9.20M1.86M8.30M7.89M10.44M6.22M11.85M8.71M13.87M24.98M28.39M27.14M25.05M21.76M17.23M5.43M2.38M0.26M
Total Current Liabilities
17.26M18.67M69.20M14.23M16.23M21.65M22.99M17.32M25.46M37.15M41.82M45.63M49.10M49.07M29.16M14.95M13.65M8.87M5.49M8.43M
Non-Current Liabilities
Non-Current Debt
0.15M0.14M0.13M0.12M0.11M0.10M0.09M0.07M0.06M0.09M0.04M0.03M0.01M0.09M0.09M0.09M
Non-Current Deffered Revenue
8.79M9.74M19.95M22.30M23.75M10.82M9.95M9.04M11.85M12.22M12.57M12.57M12.57M
Minority Interest
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
0.82M0.39M
Operating Leases
6.19M5.97M5.73M5.47M5.22M4.96M4.68M4.41M4.12M3.83M3.52M3.21M2.88M2.55M2.17M1.77M1.45M0.94M0.51M0.04M
Other Non-Current Liabilities
0.80M1.00M0.10M0.10M
Total Non-Current Liabilities
81.98M82.36M27.61M31.89M48.87M
Total Liabilities
32.80M82.78M83.36M27.70M31.99M48.87M47.71M44.10M53.40M75.50M71.45M69.38M69.65M64.42M43.90M29.29M27.68M9.90M6.09M8.56M
Shareholder's Equity
Total Debt
0.15M0.14M1.12M0.23M0.25M0.10M0.09M0.07M0.06M0.09M0.04M0.03M0.01M0.09M0.09M0.09M
Common Equity
111.89M88.29M62.47M35.92M32.48M75.93M64.84M54.78M53.70M106.89M96.25M80.50M65.51M46.12M33.81M32.83M26.49M59.02M52.93M44.20M
Liabilities and Shareholders Equity
144.69M171.07M145.83M63.63M64.48M124.80M112.55M98.89M107.10M182.39M167.70M149.88M135.16M110.54M77.71M62.12M54.17M68.92M59.02M52.77M
Retained Earnings
-338.22M-367.46M-400.30M-429.00M-440.65M-413.88M-427.14M-439.10M-442.30M-391.07M-403.74M-421.60M-438.80M-459.64M-473.50M-475.20M-482.60M-451.07M-458.30M-467.82M
Preferred Shares
0.00M0.00M0.00M0.00M
Treasury Shares